Thyroid Cancer Treatment in India: Thyroidectomy & Radioiodine Guide 2026
Priya Sharma
Oncology & Cancer Care Writer
Thyroid Cancer Treatment in India: Thyroidectomy & Radioiodine Guide 2026
Thyroid cancer is one of the most treatable cancers — but only when diagnosed accurately and managed with the right combination of surgery, nuclear medicine, and lifelong hormone monitoring. Across Africa, delayed diagnosis and limited access to nuclear medicine facilities mean that many patients reach advanced stages before receiving definitive treatment. India's endocrine surgery and nuclear medicine capabilities offer a complete solution at a fraction of Western costs.
This guide covers thyroid cancer types, the treatment pathway from surgery to radioiodine ablation, costs, the best hospitals in India, and how to plan your journey.
Understanding Thyroid Cancer: Four Types, Very Different Prognoses
Thyroid cancer is not one disease. The four main types differ substantially in behaviour, treatment, and prognosis.
Papillary thyroid carcinoma accounts for 80–85% of all thyroid cancers globally. It is slow-growing, almost always confined to the thyroid or nearby lymph nodes at diagnosis, and carries a 10-year survival rate exceeding 95% with appropriate treatment. This is the most common type seen in younger patients and women. Treatment is total thyroidectomy followed by radioiodine ablation in most cases.
Follicular thyroid carcinoma represents 10–15% of cases. It tends to spread via the bloodstream to the lungs and bones rather than lymph nodes. Prognosis is excellent for minimally invasive follicular cancer; widely invasive follicular cancer requires more aggressive management. Total thyroidectomy and radioiodine are the standard treatment.
Medullary thyroid carcinoma (MTC) arises from the C-cells that produce calcitonin — not from the follicular cells that take up iodine. Because of this, radioiodine has no role in MTC. Surgery (total thyroidectomy with lymph node dissection) is the primary treatment, with calcitonin and CEA as tumour markers for monitoring. A subset of MTC is hereditary (MEN2 syndrome), so genetic testing is recommended.
Anaplastic thyroid carcinoma is rare (less than 2% of cases) but aggressive — it does not respond to radioiodine and carries a poor prognosis. Management involves surgery where possible, external beam radiation, and systemic therapy. It is typically diagnosed in older patients and requires a multidisciplinary team approach from the outset.
For the vast majority of patients — those with papillary or follicular cancer — treatment in India is highly effective and available at a cost 70–80% lower than the USA or Europe.
The Treatment Pathway: Surgery to Radioiodine to Monitoring
For papillary and follicular thyroid cancer, treatment follows a well-established sequence.
Total thyroidectomy removes the entire thyroid gland. This is preferred over hemithyroidectomy for cancers over 1cm, bilateral disease, or aggressive subtypes, because it enables subsequent radioiodine ablation and allows thyroglobulin to be used as a tumour marker after surgery. Total thyroidectomy costs $5,000–8,000 in India, compared to $25,000–35,000 in the USA.
The procedure takes 2–3 hours under general anaesthesia. Key risks — hoarseness from recurrent laryngeal nerve injury and hypoparathyroidism from accidental removal of the parathyroid glands — are minimised by experienced endocrine surgeons who use nerve monitoring devices and attempt to identify all four parathyroid glands. At India's specialist endocrine surgery centres, complication rates are well within internationally published benchmarks.
Robotic thyroidectomy has become available at several leading Indian hospitals, including Apollo Delhi and Medanta Gurugram. The transaxillary robotic approach removes the thyroid through a small incision in the armpit, leaving no visible scar on the neck. This technique is particularly sought after by younger patients and professionals for whom neck scarring would be cosmetically or professionally significant. Cost is $8,000–12,000.
Radioiodine (I-131) ablation is administered 4–6 weeks after total thyroidectomy. The thyroid cells — and any residual thyroid tissue or microscopic thyroid cancer — uniquely take up iodine. A dose of radioactive iodine given orally destroys this tissue without affecting other organs. The patient is admitted to a dedicated radioiodine isolation room in the nuclear medicine department for 24–72 hours while radioactivity falls to safe levels. Major Indian hospitals including Tata Memorial Mumbai, AIIMS Delhi, Apollo, and Fortis have purpose-built radioiodine suites with shielded rooms and trained nuclear medicine teams.
Some patients require a second or higher dose of radioiodine if residual disease is detected on follow-up scans — a decision made based on thyroglobulin levels and whole-body radioiodine scan results.
Thyroid hormone replacement begins immediately after surgery. Since the thyroid gland is removed, the body produces no thyroid hormone. Levothyroxine (T4) is taken daily for life. In thyroid cancer management, the dose is deliberately set slightly above normal to suppress TSH — because TSH stimulates thyroid cancer cell growth. This TSH-suppressive therapy is gradually relaxed after several years in patients confirmed to be disease-free.
Thyroglobulin monitoring is the cornerstone of long-term surveillance. Thyroglobulin (Tg) is a protein produced only by thyroid cells. After total thyroidectomy and radioiodine ablation, Tg should be undetectable. A rising Tg signals recurrent or residual disease and prompts further evaluation with neck ultrasound and diagnostic radioiodine scanning. Indian oncologists provide detailed monitoring schedules and telemedicine follow-up — allowing African patients to have blood tests locally with results reviewed remotely.
Cost Comparison: India vs USA vs UK
| Procedure | India | USA | UK (Private) |
|---|---|---|---|
| Total thyroidectomy | $5,000–8,000 | $25,000–35,000 | £15,000–25,000 |
| Robotic thyroidectomy | $8,000–12,000 | $35,000–50,000 | £20,000–35,000 |
| Radioiodine ablation (I-131) | $1,500–3,000 | $8,000–15,000 | £5,000–10,000 |
| Nuclear medicine whole-body scan | $300–600 | $2,000–4,000 | £1,500–3,000 |
| Thyroglobulin + anti-Tg antibodies | $30–60 | $150–300 | £80–150 |
| Full treatment package (surgery + RAI) | $7,000–11,000 | $35,000–50,000 | £20,000–35,000 |
Even accounting for flights and 2–3 weeks of accommodation in India, the total cost for a thyroid cancer patient is a fraction of what treatment costs in the West.
Leading Hospitals for Thyroid Cancer in India
Tata Memorial Hospital, Mumbai is India's premier government cancer centre and handles the highest volume of thyroid cancer cases in the country. Its nuclear medicine department is one of the best-equipped for radioiodine therapy in Asia, with purpose-built isolated suites and experienced nuclear medicine physicians. International patients can access Tata Memorial through Arodya's coordination pathway.
Apollo Hospitals (Delhi, Chennai, Hyderabad) offer JCI-accredited endocrine surgery and nuclear medicine under one roof. Apollo's endocrine surgery teams use intraoperative nerve monitoring as standard and offer robotic thyroidectomy at the Delhi campus. For international patients who prioritise private hospital amenities, English-language records, and dedicated coordination, Apollo is consistently strong.
AIIMS Delhi is India's top public academic medical centre, with an endocrine surgery department that trains many of India's specialist thyroid surgeons. AIIMS handles complex cases including locally advanced thyroid cancer, medullary thyroid carcinoma with MEN2 genetics, and re-operative neck surgery. Costs are substantially lower than private hospitals.
Medanta The Medicity, Gurugram and Fortis Hospitals complete the tier-1 list, both offering modern endocrine surgery, laparoscopic parathyroid exploration, and nuclear medicine capabilities at competitive costs.
Planning Your Thyroid Cancer Treatment Journey
A typical itinerary for total thyroidectomy plus same-trip radioiodine ablation:
- Days 1–2: Arrival, international patient registration, pre-operative workup (blood tests, ultrasound, FNAC review, cardiac clearance)
- Days 3–4: Total thyroidectomy (2–3 hours surgery, 1 night ICU, 2 nights ward)
- Days 5–6: Discharge from surgical ward, begin levothyroxine at suppressive dose
- Days 7–28 (if radioiodine same trip): Low-iodine diet period; some patients return home and come back 4–6 weeks later for radioiodine — this is actually the more common approach, allowing the TSH to rise adequately for optimal radioiodine uptake
- Radioiodine trip (separate visit): 3–5 days including admission, dose administration, isolation period, and whole-body scan before discharge
Arodya helps patients decide whether to combine surgery and radioiodine in a single extended trip or manage them as separate visits. For most patients with straightforward papillary cancer, separating the trips is clinically optimal and logistically manageable.
Starting Your Treatment with Arodya
The first step is sending your diagnostic reports — fine-needle aspiration cytology (FNAC), ultrasound neck, and any prior imaging — to Arodya for clinical review. Our oncology coordinator team reviews your case, recommends the appropriate hospital and surgical team based on your cancer type and complexity, and provides a written cost estimate within 72 hours.
Submit your case through our intake form to get the process started. Whether your diagnosis is a recent incidental finding or a long-standing concern, India's thyroid cancer centres have the expertise and the pricing to make definitive treatment accessible.
Thyroid cancer, caught and treated properly, is among the most curable of all cancers. The right team, the right surgery, and disciplined follow-up — India offers all three, and Arodya connects you to it.
For a broader overview of cancer treatment costs, see our complete India vs USA cost comparison guide.
